Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
Le dernier exercice comptable publié pour cette entreprise remonte à 2022. Les données ci-dessous peuvent ne plus refléter sa situation actuelle.
QST LAB : revenue, balance sheet and financial ratios
QST LAB is a French company
founded 8 years ago,
specialized in the sector Fabrication d'équipements d'irradiation médicale, d'équipements électromédicaux et électrothérapeutiques .
Based in STRASBOURG (67200),
this company of category PME
shows in 2022 a revenue of 838 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-08-08
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
Synthèse
Santé financière :
Saine
Aucun signal de fragilité majeur : rentabilité positive et structure financière équilibrée.
In summary, QST LAB posts positive profitability over the latest financial year. Its financial structure is solid, with debt well contained relative to its sector.
Revenue and income statement
In 2023, QST LAB generates positive net income of 822 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2023: 642 k€ -> 822 k€.
Revenue (2022)
?
838 051 €
Gross margin (2022)
?
720 694 €
EBITDA (2022)
?
677 298 €
Net income (2022)
?
641 592 €
EBITDA margin (2022)
?
80.8%
Loading income statement...
The detailed income statement is not available for this company (simplified accounts or confidential data).
Assets
Loading data...
Assets balance sheet data not available for this company
Liabilities
Loading data...
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. Compared with its sector, this ratio places the company among the best positioned (sector median: 13.6%). Financial autonomy (= Equity / Total assets x 100) reaches 85%. Compared with its sector, this ratio places the company among the best positioned (sector median: 39.9%). Cash flow represents 56.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Compared with its sector, this ratio places the company among the best positioned (sector median: 4.8%).
Financial autonomy (2022)
?
85.05%
Cash flow / Revenue (2022)
?
56.21%
Repayment capacity (2022)
?
0.0
Asset age ratio (2022)
?
6.0%
| Indicator |
2022 |
2023 |
| Debt ratio |
0.0 |
0.0 |
| Financial autonomy |
85.045 |
89.236 |
| Repayment capacity |
0.0 |
None |
| Cash flow / Revenue |
56.208% |
None% |
Sector positioning
Q1: 1.19%
Med: 13.6%
Q3: 53.98%
Excellent
In 2023, the debt ratio of QST LAB (0.0%) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Q1: 22.24%
Med: 39.89%
Q3: 64.76%
Excellent
In 2023, the financial autonomy of QST LAB (89.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Q1: 0.0 years
Med: 0.27 years
Q3: 2.69 years
Excellent
In 2022, the repayment capacity of QST LAB (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 6.61. Compared with its sector, this ratio places the company among the best positioned (sector median: 2.8).
Liquidity ratio (2022)
?
6.61
Interest coverage (2022)
?
0.0
| Indicator |
2022 |
2023 |
| Liquidity ratio |
6.6051 |
9.15536 |
| Interest coverage |
0.0 |
None |
Sector positioning
Q1: 1.95
Med: 2.83
Q3: 3.93
Excellent
-5 pts over 2 years
In 2023, the liquidity ratio of QST LAB (9.16) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Q1: -2.03x
Med: 0.88x
Q3: 3.24x
Average
In 2022, the interest coverage of QST LAB (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Overall, WCR represents 77 days of revenue, i.e. 0 € to permanently finance.
Operating WCR (2022)
?
180 064 €
Customer credit (2022)
?
77 j
Supplier credit (2022)
?
34 j
Inventory turnover (2022)
?
24 j
WCR in days of revenue (2022)
?
77 j
| Indicator |
2022 |
2023 |
| Operating WCR |
180 064 € |
0 € |
| Inventory turnover (days) |
24 |
0 |
| Customer payment term (days) |
77 |
0 |
| Supplier payment term (days) |
34 |
0 |
Positioning of QST LAB in its sector
Valuation estimate
Based on 93 transactions of similar company sales
(all years),
the value of QST LAB is estimated at
1 033 263 €
(range 252 593€ - 3 435 072€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
1 033 263 €
Range: 252 593€ - 3 435 072€
Section all-time
Aggregated at NAF section level
Valuation method used
Net Income Multiple
822 133 €
×
1.3x
=
1 033 264 €
Range: 252 593€ - 3 435 072€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 93 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
- EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
- Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
- Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Top companies in Fabrication d'équipements d'irradiation médicale, d'équipements électromédicaux et électrothérapeutiques
Largest companies by revenue in the sector Fabrication d'équipements d'irradiation médicale, d'équipements électromédicaux et électrothérapeutiques :
Frequently asked questions about QST LAB
What is the revenue of QST LAB ?
The revenue of QST LAB in 2022 is 838 k€.
Is QST LAB profitable?
Yes, QST LAB generated a net profit of 822 k€ in 2023.
Where is the headquarters of QST LAB ?
The headquarters of QST LAB is located in STRASBOURG (67200), in the department Bas-Rhin.
Where to find the tax return of QST LAB ?
The tax return of QST LAB is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does QST LAB operate?
QST LAB operates in the sector Fabrication d'équipements d'irradiation médicale, d'équipements électromédicaux et électrothérapeutiques (NAF code 26.60Z). See the 'Sector positioning' section above to compare the company with its competitors.